文档介绍：急诊快速性心房颤动治疗药物比较
【摘要】目的:探讨急诊中控制快速型心房颤动心室率的安全有效药物。方法:选取我院2009年3月至2010年12月急诊科快速性心房颤动患者79例,按照治疗方法分为索托洛尔组、维拉帕米组和西地兰组。各组均静脉注射给药,目标心室率设定为100 次/min,观察并对比各组的达标时间。结果:%,%,%。三组治疗前、后心室率比较差异具有统计学意义(P<)。结论:索托洛尔注射液治疗快速性心房颤动比维拉帕米和西地兰静脉推注临床效果好,具有时间短,安全性高的特点,值得在临床中推广应用。
【关键词】急诊;快速性心房颤动;治疗观察
[ABSTRACT] Objective: To investigate the safe and effective drugs to treat rapid atrial fibrillation. Methods: A total of 79 patients with rapid atrial fibrillation were divided into sotalol group, verapamil group and cedilanid group in Emergency Department of our hospital from March 2009 to December 2010, and all were administered intravenously. The target heart rate was set at 100 times/min. The duration was observation pared among three groups. Results: The total efficacy of sotalol group was %, % in verapamil group, and % in cedilanid group. And there was significant difference in ventricular rate among three groups(P<). Conclusions: The treatme
nt of sotalol is more effective than verapamil and cedilanid in treating rapid atrial fibrillation . It is of short time, high security, and is worthy clinical application.
[KEY WORDS] Emergency; Rapid atrial fibrillation; Efficacy
快速性心房颤动是内科急诊最为常见的心律失常急诊之一,国、内外学者研究发现快速性房颤容易导致血栓栓塞性疾病进而甚至导致中风发生[1]。有数据表明快速性心房颤动导致中风的发生率是其他病因的2倍[2],已被认为是中风发病、死亡的独立预警因素。因而,快速有效地控制心室率在100 次/ min 以下是治疗的关键,对